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Abstract
Background: The machinery of early HIV-1 replication still remains to be elucidated. Recently the
viral core was reported to persist in the infected cell cytoplasm as an assembled particle, giving rise
to the reverse transcription complex responsible for the synthesis of proviral DNA and its
transport to the nucleus. Numerous studies have demonstrated that reverse transcription of the
HIV-1 genome into proviral DNA is tightly dependent upon proper assembly of the capsid (CA)
protein into mature cores that display appropriate stability. The functional impact of structural
properties of the core in early replicative steps has yet to be determined.
Results: Here, we show that infectivity of HIV-1 mutants bearing S149A and S178A mutations in CA
can be efficiently restored when pseudotyped with vesicular stomatitis virus envelope glycoprotein,
that addresses the mutant cores through the endocytic pathway rather than by fusion at the plasma
membrane. The mechanisms by which these mutations disrupt virus infectivity were investigated.
S149A and S178A mutants were unable to complete reverse transcription and/or produce 2-LTR
DNA. Morphological analysis of viral particles and in vitro uncoating assays of isolated cores
demonstrated that infectivity defects resulted from disruption of the viral core assembly and
stability for S149A and S178A mutants, respectively. Consistent with these results, both mutants
failed to saturate TRIM-antiviral restriction activity.
Conclusion: Defects generated at the level of core assembly and stability by S149A and S178A
mutations are sensitive to the way of delivery of viral nucleoprotein complexes into the target cell.
Addressing CA mutants through the endocytic pathway may compensate for defects generated at
the reverse transcription/nuclear import level subsequent to impairment of core assembly or
stability.
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Introduction
The genome of the human immunodeficiency virus type 1
(HIV-1) is packaged within a conical shaped core formed
by the viral capsid protein (CA) and delivered to the host
cell cytoplasm upon fusion of the viral and cell mem-
branes. Establishment of viral replication then requires
the genomic RNA to be reverse transcribed into a double
stranded proviral DNA. Upon completion of the reverse
transcription (RT), full-length HIV-1 DNA associates into
a functional pre-integration complex imported through
the nuclear pore before integration into the host chromo-
some. Completion of HIV-1 RT appears to be a timely reg-
ulated process. Indeed, HIV-1 DNA synthesis is limited in
intact viral core particles where late RT products are less
efficiently synthesized than early DNA intermediates
[1,2]. The synthesis of a complete viral DNA able to sup-
port efficient HIV-1 replication has formerly been
assumed to depend on HIV-1 conical core disorganization
and release of the reverse transcription complex (RTC) in
the cell cytoplasm [3-5]. However, recent studies reported
that CA may remain associated to the RTC in a ratio simi-
lar to that found in extracellular particles [6] and the pres-
ence of intact conical structures docked at the nuclear pore
has been detected by electron microscopy imaging [7].
Accordingly, HIV-1 cores may not dissociate immediately
after the viral fusion, but rather remain largely intact for at
least a portion of the process from the initiation of RT to
the synthesis of the central flap structure [7,8]. This model
is further supported by the ability of RT to progress effi-
ciently in intact virions, allowing the synthesis of full-
length minus strand DNA in this core fraction, without
requirement for an uncoating activity [2]. In this context,
additional evidence for the persistence of assembled cores
in the target cell has been provided through the ability of
the tripartite motif (TRIM) family of antiviral factors to
restrict HIV-1 replication in non-permissive cells through
the recognition of a polymeric array of CA molecules
present in intact cores [9-11]. The completion of viral
DNA synthesis finally depends on the ability of the RTC
to be addressed to an appropriate compartment of the
infected cell. Indeed, drugs altering the integrity of the
cytoskeleton [12] and RNA interference targeting the actin
nucleator Arp2/3 complex [13] inhibit post-entry steps of
the retroviral cycle. These data agree with imaging analysis
in living cells showing that fluorescent HIV-1 complexes
migrate as assembled cores along the actin cytoskeleton
and microtubule network before being addressed to the
microtubule-organizing center in the perinuclear region
[6] or even to the nuclear pore itself [7] where uncoating
may take place.
Mature HIV-1 cores are organized as a fullerene cone com-
posed of a lattice of hexamerized CA protein [14,15].
According to structural studies, monomeric CA folds into
two distinct globular domains: the N-terminal domain
(NTD) (residues 1 to 145) and the C-terminal domain
(CTD) (residues 151–231) are connected by a short flexi-
ble linker that folds in a 310 helix upon oligomerization of
CA [16-19]. Based on crystal structure data and cryoelec-
tron microscopy reconstructions of soluble CA that spon-
taneously assembled into helical tubes and cones, models
have been elaborated in which hexameric contacts at the
NTD of adjacent CA drive the formation of the viral cores
[15,20] while the CTD directs Gag-Gag precursor oli-
gomerization between adjacent hexamers, linking and sta-
bilizing hexameric rings into a continuous lattice
[15,16,19,21]. Interactions were finally demonstrated
between the NTD and CTD of adjacent hexamers that sta-
bilize this network [20,21]. Mutational studies have
widely demonstrated that synthesis of viral DNA and sub-
sequent ability of HIV-1 to replicate into the host cells are
tightly dependent upon the proper assembly and matura-
tion of the viral core [22-25]. Moreover, the success of
early post-entry events in the target cell requires an opti-
mal stability of the incoming core [26]. This observation
agrees with the existence of a fine regulation of the assem-
bly/uncoating process. In this context, the possible contri-
bution of post-translational modifications (i. e.
phosphorylation) has been suggested as a candidate
mechanism regulating the reversible nature of CA mono-
mers interactions required for HIV-1 to assemble or disas-
semble core structures [27,28]. S109, S149 and S178, located
in the NTD, the linker domain and the CTD of CA, respec-
tively, have been identified as major phosphorylation
sites in CA. Individual alanine substitutions at these posi-
tions were reported to abolish viral replication at early
post entry steps [27]. However, the role of CA phosphor-
ylation in virus replication is not clearly understood. In
the present study, we took advantage of early post-entry
defects reported for HIV-1 mutants bearing S109A, S149A
and S178A substitutions in CA to investigate the functional
role of the CA shell in early steps of replication. Based on
saturation experiments performed in restrictive monkey
cells, we found that all three mutants were unable to satu-
rate TRIM-mediated restriction, indicating that they all
display alterations in core structure. Elucidating the mech-
anisms by which these mutations disrupt virus infectivity,
using biochemical and morphological analyses of viral
particles and uncoating assays of envelope-stripped cores,
demonstrated that alanine substitutions of S149 and S178
residues generated mild morphological defects or
impaired stability of the core, respectively. S109A resulted
in drastic alteration of core assembly and incomplete Gag
precursor cleavage. Surprisingly, we found that when
pseudotyped with the vesicular stomatitis virus glycopro-
tein (VSV-G), S149A and S178A, but not S109A, became
competent for 2-LTR circle formation and established pro-
ductive infection of the host cell. Altogether our data indi-
cate that the appropriate shape and stability of the HIV-1
core are required for reverse transcription/nuclear importRetrovirology 2008, 5:57 http://www.retrovirology.com/content/5/1/57
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when delivered by fusion at the plasma membrane but
dispensable when addressed through the endocytic path-
way. In light of these results, we propose an additional
function of the core in the HIV-1 life cycle, concerning
replicative steps lying between the fusion event at the
plasma membrane of the host cell and the integration of
the viral genome.
Results
Infectivity of S149A and S178A mutants is restored when 
delivered to the host cell through the endocytic pathway
The function of S109, S149 and S178 residues, positioned in
the N-terminus, the interdomain linker and the C-termi-
nus of CA respectively (see location in Figure 1), was ana-
lyzed using NL4.3 virions bearing an alanine substitution
at each position. Viruses were produced by transfection
experiments of 293T cells with pNL4.3 or S109A, S149A and
S178A mutated molecular clones and used to infect the
MAGIC-5B indicator cell line (Figure 2A). All three
mutants were found to be poorly infectious compared to
the NL4.3 wild-type (WT) viruses when viral input was
normalized according to reverse transcriptase (RTase)
activity. These data confirm replication defects previously
reported for S109A, S149A and S178A mutants [27]. Infectiv-
ity of HIV-1 mutants characterized by post-entry blocks
has been previously reported to be greatly influenced by
the route of viral entry. Pseudotyping with envelope from
other viruses enables some HIV-1 mutants to bypass early
post entry blocks [29-31]. Incorporation of VSV-G, which
allows viruses to enter the target cell using the endocytic
low pH pathway, was found to restore infectivity of
viruses bearing mutations/deletions in the Nef accessory
gene [30] or of those lacking the ability to incorporate
cyclophilin A (CypA) [31]. For testing similar effects,
S109A, S149A and S178A mutants pseudotyped with VSV-G
envelope were generated by co-transfection of proviral
clones with a plasmid expressing VSV-G. VSV-G-pseudo-
typed S109A, S149A and S178A viruses (referred below as
VSV-G-S109A, VSV-G-S149A and VSV-G-S178A respectively)
were normalized for RTase content and used in single-
round infectivity assays of the MAGIC-5B cell line (Figure
2C). As expected, when pseudotyped with VSV-G, a strong
enhancement of infectivity was observed for WT virions as
compared to non-pseudotyped viruses (data not shown).
Interestingly, pseudotyping with VSV-G significantly
restored infectious properties of S149A and S178A mutants
to levels observed for VSV-G-WT viruses. In contrast, VSV-
G-S109A viruses remained weakly infectious. Similar
results were obtained using an extended range of viral
input (Figure 2D and [Additional file 1]). At lower doses
(100 to 1,000 cpm of RTase activity), VSV-G pseudotyped
viruses did not saturated the cell culture, as less than 90%
of the cells were found to be infected using a direct β-
galactosidase staining assay (data not shown). Accord-
ingly, the infectivity rescue observed for the VSV-G-S149A
and VSV-G-S178A viruses cannot be ascribed to an overes-
timation due to the use of saturating doses of VSV-G-WT.
MAGIC-5B cells were next infected with S149A or S178A
viruses expressing either VSV-G or HIV Env using doses
adjusted to generate comparable levels of strong-stop
DNA copies in the infected cells as defined by qPCR exper-
iments. In these cells, β-galactosidase activity was
observed to be dramatically enhanced when S149A or
S178A particles were delivered to the cell by the endocytic
pathway [Additional file 2]. Finally, replication of VSV-G-
S149A and VSV-G-S178A was abolished when MAGIC-5B
cells were maintained in the presence of 20 μM AZT indi-
cating that LTR-transactivation is not due to a pseudo-
transduction artefact. Similar pseudotyping experiments
were performed using the amphotropic murine leukaemia
virus (MLV) glycoprotein, which allows infection of the
target cell through a pH-independent fusion with the
plasma membrane [32]. In these conditions, infectivity of
MLV Env-S109A and MLV Env-S149A was comparable to
Schematic representation of HIV-1 CA Figure 1
Schematic representation of HIV-1 CA. Location of α-helix and β-sheets identified in the N-terminal (NTD) and C-ter-
minal (CTD) domain of CA is represented. The cyclophilin binding domain (CypA) and the Major Homology Region (MHR) are 
marked. Positions of S109, S149 and S178 residues are indicated.
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Relative infection of pseudotyped CA mutant viruses Figure 2
Relative infection of pseudotyped CA mutant viruses. Infectivity of normalized amounts (10,000 cpm RTase activity) of 
WT viruses and CA mutants expressing HIV-1 envelope (A) or having incorporated MLV (B) or VSV (C) glycoprotein was 
monitored using the MAGIC-5B indicator cell line. (C) Replication of VSV-G pseudotyped WT and CA mutants (10,000 cpm 
RTase activity) was inhibited by addition of 20 μM AZT to the culture medium. Values are expressed as a percentage of WT 
infectivity. (D) Rescue of CA mutant infectivity by VSV-G pseudotyping was investigated at low infectious doses (100 to 1,000 
cpm RTase activity) by measuring o-nitrophenyl β-D-galactopyranoside hydrolysis in MAGIC-5B. Each value represents an 
average of three experiments performed in duplicate ± standard deviation.
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that of the corresponding mutants expressing HIV Env.
Indeed, β-galactosidase activity generated in MAGIC-5B
cells was found to be 2% vs 4.3% for MLV Env-S109A and
non pseudotyped S109A viruses respectively or 6% vs 4%
for MLV Env-S149A and non-pseudotyped S149A viruses
respectively when compared to WT virus expressing the
corresponding envelope glycoproteins. (Figure 2A and
2B). Infectivity of S178A mutant was found slightly
increased when pseudotyped with MLV Env (19% com-
pared to 13% observed for MLV Env-S178A and non pseu-
dotyped S178A viruses respectively). Infectivity defects
associated with substitutions in CA can thus be rescued to
variable extent by incorporation of different envelopes.
Infectivity of S149A and S178A mutants was efficiently
restored following VSV-G incorporation. Differences in
infectivity observed between HIV Env expressing viruses
and VSV-G pseudotypes suggest that shunting the viral
core in the target cell through a pH-dependent endocytic
pathway may bypass post-entry defects generated by
mutation of S149 and S178 residues in CA.
CA mutants display distinct behaviour during RT
Next, we examined the ability of CA mutants to accom-
plish early post entry events (i.e. RT). First of all, we tested
whether mutations in CA impaired the RT machinery
incorporated within viral particles using endogenous
reverse transcription (ERT) experiments. This approach
was successfully used to show alterations generated by CA
mutations in Rous sarcoma virus [33]. Normalized
amounts of cell free virions, determined by exogenous
RTase activity, were permeabilized and incubated in the
presence of dNTPs to promote DNA synthesis primed by
the endogenous tRNA primer using the RNA genome as a
template. Viral DNA synthesis was then monitored by
qPCR detection of strong-stop and second-strand transfer
DNAs. RT efficiency was established by calculating the
fraction of second-strand transfer products generated rela-
tive to strong-stop DNA copies expressed as a percentage.
As shown in Figure 3A, ERT activity occurred for all viruses
tested indicating that early and late HIV-1 DNAs were pro-
duced at least as efficiently by CA mutants as WT viruses
when viral cores were permeabilized through the use of
detergent. Unexpectedly, ERT level was increased by 2.5
fold for the S149A mutant. Thus, alanine substitutions in
CA did not markedly impair the formation of a functional
nucleoprotein complex within the virions. We next ana-
lyzed RT capacities of CA mutants in the host cell. Total
DNA was prepared from MAGIC-5B cells infected for 24
hours with normalized amounts of WT or CA mutant
viruses and subjected to qPCR amplification using a spe-
cific set of primers allowing detection of RT intermediates.
As shown in Figure 3B, strong-stop DNA was present at a
similar ratio in cells infected with WT (2.9 × 106 copies/
106 cells) or CA mutant viruses (from 2.7 to 3.9 × 106 cop-
ies/106 cells). All viruses tested were thus competent for
fusion with the target cell membrane and inhibition of
replication observed for S109A, S149A and S178A mutants
occurred at a post-fusion step, as previously proposed
[27]. Reverse transcription intermediates were efficiently
detected in cells infected with WT virus (first-strand trans-
fer, full-length minus strand and second-strand transfer
DNAs were 8 × 105; 2.5 × 105 and 2 × 105 copies/106 cells).
In cells infected with the S178A mutant, first-strand trans-
fer, full-length minus strand and second-strand transfer
DNAs copies ranged from 70 to 95% levels quantified
from cells infected by WT viruses. In contrast, RT was
found most drastically altered in cells infected with S149A
virus, as synthesis of full-length minus strand and second-
strand transfer DNAs was reduced by nearly 70% com-
pared to control conditions. Finally, level of first strand
transfer DNA was significantly decreased and full-length
minus strand DNA synthesis was almost abolished in cells
infected with S109A viruses indicating that early reverse
transcription was drastically reduced in these cells. We
next tested the presence of 2-LTR circles in infected cells.
2-LTR circles are unproductive forms of viral DNA created
by end-to-end ligation, that can be used as a reporter for
nuclear import of the viral genome, since it localizes pre-
dominantly in the nucleus of infected cells [34]. Using
primers that specifically amplify the LTR-LTR junction, we
found that all CA mutants were impaired for 2-LTR circle
formation (Figure 3C). Altogether, these data indicate that
CA mutations impair early replication at different steps.
S109A mutant was unable to accomplish RT. In contrast,
S149A and S178A mutants produced different levels of sec-
ond-strand transfer DNA and were impaired in their abil-
ity to produce 2-LTR circles.
VSV-G pseudotyping of S149A and S178A mutants rescues 2-
LTR circle formation
Having demonstrated that VSV-G incorporation rescues
infectivity of S149A and S178A mutant particles, we investi-
gated the ability of these pseudotyped mutants to synthe-
size proviral DNA. Strong-stop and second-strand transfer
DNAs were quantified from infected cells by qPCR exper-
iments and RT efficiency was calculated as described for
ERT experiments (see above). Similar RT efficiency was
observed in cells infected with VSV-G-S149A, VSV-G-S178A
or VSV-G-WT viruses (Figure 3D). This indicates that RT
progressed efficiently for these viruses. In contrast, RT pro-
gression remained dramatically impaired in cells infected
with VSV-G-S109A viruses. These data were next compared
to RT efficiency calculated from cells infected with viruses
expressing HIV Env. Following VSV-G incorporation, RT
efficiency was increased by 11 and 15-fold in cells infected
with WT and S178A viruses respectively (Figure 3D). This
stimulation was also observed for VSV-G-S109A, despite
proviral DNA synthesis remaining dramatically ineffi-
cient. Interestingly, RT efficiency was enhanced by 38-fold
when S149A viral particles contained VSV-G. Formation ofRetrovirology 2008, 5:57 http://www.retrovirology.com/content/5/1/57
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Endogenous reverse transcription in cell free particles and proviral DNA synthesis in cells infected with WT or CA mutants  expressing HIV Env or VSV-G Figure 3
Endogenous reverse transcription in cell free particles and proviral DNA synthesis in cells infected with WT or 
CA mutants expressing HIV Env or VSV-G. (A) Competence for ERT of WT and mutant cell free particles after perme-
abilization and incubation with dNTPs. Efficiency of DNA synthesis is estimated as the ratio of second-strand transfer to 
strong-stop DNA detected by qPCR. Data presented are representative of three different experiments performed in duplicate. 
(B) MAGIC-5B cells were infected with normalized amounts of DNAse-treated WT, S109A, S149A or S178A viruses. Twenty-
four hours post-infection, cells were lysed and RT intermediates were quantified by qPCR using primers specific for strong-
stop or first-strand transfer or full-length minus strand or second-strand transfer DNAs. Results are the mean of three sepa-
rate experiments performed in duplicate and are expressed as a percentage of values obtained with WT ± standard deviation. 
2-LTR circle formation was detected by amplification of the LTR-LTR junctions in total DNA extracted from MAGIC-5B cells 
infected with WT or CA mutants expressing HIV Env (C) or pseudotyped with VSV-G (E). Results are the mean of three sep-
arate experiments performed in duplicate and are expressed as a percentage ± standard deviation of the values obtained with 
WT. (D) Efficiency of RT progression was evaluated in MAGIC-5B cells infected with WT or CA mutants expressing either 
HIV-Env or VSV-G. Values are expressed on a logarithmic scale and are representative of three separate experiments per-
formed in duplicate. For each virus studied, RT efficiency in cells infected through VSV-G relative to that observed in cells 
infected with the corresponding virus expressing HIV-Env is indicated as a ratio.
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2-LTR DNA was next investigated in cells infected with
VSV-G-S149A or VSV-G-S178A viruses (figure 3E). Consist-
ent with infectivity assays, 2-LTR DNA was produced effi-
ciently in cells infected with VSV-G-S149A and VSV-G-
S178A. As expected, 2-LTR circles could not be amplified
from cells infected with VSV-G-S109A. Altogether, our data
indicate that infection through the endocytic pathway
restored the ability of S149A and S178A mutants to produce
2-LTR DNA. Moreover, progression of RT from early to
late steps was stimulated upon incorporation of VSV-G for
all viruses studied, with a stronger effect observed for the
S149A mutant. In conclusion, delivering the viral genome
through a different route may enhance RT progression or
possibly steps that allow nuclear import of the viral
genome.
Impact of S109A, S149A and S178A mutations on core 
recognition by TRIM family restriction factors
We next examined the capacity of S109A, S149A and S178A
mutants to saturate the TRIM family proteins. TRIM pro-
teins expressed in some Old World monkey cells effi-
ciently restrict post-entry steps of HIV-1 replication [9,10].
While the precise mechanisms of this restriction remain
unclear, the restrictive properties of TRIM factors are cor-
related with their capacity to interact with the incoming
viral cores [35,36]. TRIM recognition is sensitive to the
maturation of the CA-p2-NC junctions, to the stability of
the capsid shell and finally to the organization and fold-
ing of exposed surfaces of the assembled core [11,36,37].
We thus took advantage of these characteristics to evaluate
the impact of S109A, S149A and S178A substitutions on
structural properties of the corresponding cores. HIV-1
infection in Cos7 cells is restricted by TRIM5α. This
restriction can be saturated in the presence of virus-like
particles or elevated amounts of saturating virus that dis-
plays properly folded cores with an appropriate stability
[38]. To evaluate the impact of S109A, S149A and S178A
mutations on core integrity, Cos7 cells were infected with
increasing amounts of VSV-G pseudotyped WT or S109A or
S149A or S178A virions and challenged with a fixed amount
(200 ng CA protein defined by anti-CA ELISA assay) of an
HIV-1 reporter virus bearing a GFP sequence in place of
the nef gene (HIV-1R7-GFP) [39]. This dose was previously
ascertained to allow expression of GFP at less than 1% in
OMK cells (data not shown). When cells were co-infected
with increasing amounts of pseudotyped WT virus, an
increasing percentage of GFP-positive cells could be
detected by FACS analysis indicating a dose-dependent
enhancement of HIV-1R7-GFP reporter virus replication
(Figure 4). When similar experiments were performed sat-
urating Cos7 cells with increasing amounts of S109A,
S149A, S178A viruses, GFP expression levels remained
extremely reduced, indicating that TRIM5α-mediated
restriction of HIV-1R7-GFP replication could not be over-
come by the presence in the infected cells, of cores bearing
S109A, S149A or S178A mutations. Similar results were
obtained using the OMK cell line that expresses the TRIM-
Cyp restriction factor, which results from a retrotransposi-
tion event of the cyclophilin A pseudogene into the
TRIM5 locus [10,40] (data not shown). In conclusion, CA
mutants were thus poorly recognized by TRIM5α in Cos7
cells or TRIMCyp in OMK cells. As TRIM recognition of
the incoming viral cores requires the proper intermolecu-
lar packing of adjacent CA molecules, our results indicate
that substitution of serine residues in CA generates modi-
fications in the capsid shell that render viral cores resistant
to the cellular restriction machinery.
In vivo assembly and maturation of S109A, S149A and S178A 
mutant viruses
The effect of CA mutations on Gag assembly was investi-
gated by analyzing cell free viral particles morphology in
electron microscopy experiments. As shown in Figure 5A
and 5B, the presence of normal-sized mature virions was
observed in preparations of WT, S149A and S178A particles.
In contrast, S109A particles displayed a significant decrease
in size. No modification of the sphericity index was
observed for any mutant tested (data not shown). The
presence of unambiguous cone-shaped nucleoids was
observed in WT and S178A viruses. In contrast, S149A parti-
cles displayed mild morphological defects characterized
by irregularly shaped cores. When S109A viruses were
examined, no core was observed and viruses contained
TRIM5α saturation assay by WT or CA mutants Figure 4
TRIM5α saturation assay by WT or CA mutants. 
Cos7 cells incubated with increasing amounts of VSV-G pseu-
dotyped WT or S109A, S149A or S178A-mutated virions were 
challenged with fixed infectious doses of HIV-1R7-GFP indica-
tor virus. The percentage of replication (GFP positive cells) 
was quantified by flow cytometry at day 2 post challenge. Val-
ues are plotted as the percentage of GFP positive cells as a 
function of the amount of VSV-G pseudotyped virus used for 
saturation of TRIM5α proteins. Data presented are repre-
sentative of two different experiments.
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aggregates that were acentric and presented a lobular
aspect.
The Gag expression and processing pattern was further
characterized at the level of cell-associated proteins and
cell free particles in immunoblotting experiments. When
viral lysates of 293T transfected cells were reacted with
anti-CA mAbs, expression and processing of the Gag struc-
tural precursor were found to be similar for cells express-
ing WT and mutants viruses (Figure 6A). Analyzing cell
free virions normalized according to RTase activity (Figure
6B), the expected ratio of Gag precursor, p41 intermediate
and mature CA were observed for S149A and S178A virions
as compared to WT. In contrast, S109A virions presented an
accumulation of unprocessed Gag and processing inter-
mediates, including p41 and p25. Hence, Gag maturation
is compromised by S109A mutation in CA. All mutant
viruses were found to package processed Pol (p51 and
p66) proteins at a normal level relative to WT virions (Fig-
ure 6C). Finally, no significant difference in the levels of
CypA incorporation was detected from WT and CA
mutants (Figure 6D). Altogether these data indicate that
the S178A mutation does not compromise the ability of CA
to assemble in vivo. The S149A mutation generates subtle
core morphological defects despite efficient maturation of
CA. Finally, production of viral particles with normally
assembled and mature cores strictly depends upon S109
integrity.
Contribution of S109, S149 and S178 residues to HIV-1 core 
stability
Stability of WT and mutant cores was addressed using an
in vitro dissociation assay. The corresponding cell-free par-
ticles were envelope-stripped by ultracentrifugation
through a sucrose cushion overlaid with detergent as
described in Materials and Methods. Preparations of WT
cores processed for negative staining and electron micros-
copy revealed recognizable intact, cone-shaped particles
Analysis of WT and mutants virion morphology Figure 5
Analysis of WT and mutants virion morphology. (A) Virus particles produced from 293T cells transfected with WT, 
S109A, S149A or S178A molecular clones were processed as described in "Materials and Methods" and imaged in thin-layer elec-
tron microscopy. Aberrant cores are indicated by an arrow. Identical scale is used for all images (scale bar = 60 nm). (B) Diam-
eter distribution observed for WT and mutant viruses. Mean diameters are indicated.
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with a small fraction of unstructured aggregates and
spherical structures, typical of CA monomers (Figure 7A).
Cone shaped structures were also predominantly
observed from preparations of S178A cores and more rarely
from S149A samples. On the contrary, aberrant aggregates,
but no core, were isolated from S109A mutants. These
results are consistent with data obtained from the bio-
chemical and morphological analyses of entire S109A par-
ticles. Due to the aberrant morphology of the structures
purified, the S109A mutant was excluded from subsequent
experiments. Preparations of WT, S149A and S178A cores
were then incubated for 2 h at 37°C in conditions that
were previously reported to allow core destabilisation
[26]. Uncoating efficiency was determined after centrifu-
gation of the reaction mixture and a measure of CA con-
centration in the soluble (monomeric CA) and pellet
fractions (assembled cores) was made using an anti-CA
ELISA assay. In these experimental conditions, incubation
at 37°C efficiently promoted dissociation compared to
incubation at 4°C (data not shown). When mutant cores
Western-blot analysis of cell free virions and Gag expression in cell lysates Figure 6
Western-blot analysis of cell free virions and Gag expression in cell lysates. 293T cells were transfected with WT or 
derived CA mutant HIV-1 molecular clones. Cell-associated proteins (A) or normalized amounts of viral particles present in 
culture supernatant (B) were processed for Western blotting experiments as described under "Materials and Methods" and 
revealed with anti-CA mAbs. Position of unprocessed Gag, p41 and p25 processing intermediates and mature CA is indicated. 
(C) Expression and maturation of the RTase subunits were determined from pelleted cell-free virions using anti-RTase mAbs. 
(D) Incorporation levels of CypA into WT and mutant virions were determined using anti-CypA. The mean CypA to CA ratio 
determined by densitometry scanning from three different experiments is indicated for each lane.
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were assayed, no significant variation in uncoating effi-
ciency was observed for S149A cores compared to WT (Fig-
ure 7B). Similar incubation of S178A core particles
revealed an increased dissociation rate. Thus alanine sub-
stitution of the S178 residue in CA decreases the stability of
HIV-1 cores.
Discussion
Earlier observations have identified S109, S149 and S178 res-
idues as major phosphoacceptor sites in CA [27]. While
their precise contribution to HIV-1 replicative capacity
remains to be defined, each residue was previously
reported to be required for viral replication at the level of
post entry steps [27]. Here we took advantage of this phe-
notype to study the relationships that exist between struc-
tural properties of the core and early post-entry events of
HIV-1 infection. Analyzing key steps of the viral life cycle,
we demonstrate that all three residues are crucial for the
formation of properly assembled HIV-1 cores and deal
with distinct functions, including Gag precursor matura-
tion, mature CA assembly, or stabilizing the assembled
core structure, for S109, S149 and S178 residues respectively.
We confirm that alanine substitution at each site impairs
HIV-1 replication during early post-entry steps, and we
further demonstrate that replication blocks occur at differ-
ent steps of the RT/nuclear import process. Unexpectedly,
replication defects could be efficiently overcome by pseu-
dotyping S149A and S178A viral particles with VSV-G,
which was found to enhance late DNA synthesis and/or 2-
LTR circle production. These results indicate that the
impact of structural properties of HIV-1 cores on post-
fusion events is sensitive to the way of delivery of the HIV-
1 core to the target cell.
Electron microscopy analyses and biochemical experi-
ments did not reveal any morphological or maturation
defect in the S178A mutant. This mutant was, however,
unable to saturate the TRIM5α/TRIMCyp restriction fac-
tors. Moreover, the corresponding envelope stripped cores
dissociated in vitro more rapidly than WT cores, indicating
that the loss of infectivity and post-entry blocks observed
for the S178A mutant correlate to modifications in in vitro
core stability. The S178 residue lies at the beginning of α-
helix 9 involved both in CTD dimerization and N- to C-
domain intersubunit interactions that are crucial for the
formation of the CA lattice [16,19,20]. According to struc-
tural models, the presence of a neutral side chain at posi-
tion S178 was proposed to participate in an electrostatic
intersubunit repulsion of the CTD domains maintaining
an appropriate stability of the CA lattice by increasing the
inter-hexamer distance [41]. Our data, confirming these
models, agree that the integrity of the S178 residue pro-
vides a stabilizing effect on the structure of the assembled
core. Proviral DNA analysis revealed that the S178A mutant
was only slightly affected in synthesis of the different DNA
intermediates checked. However, 2-LTR production was
completely impaired. This phenotype is very reminiscent
of that reported by the Aiken laboratory for the Q63A/
Q67A double mutant that displayed an unstable core
structure and which was competent for RT [26,42]. Con-
Analysis of WT and mutants core morphology and stability Figure 7
Analysis of WT and mutants core morphology and stability. (A) Envelope of WT and CA mutants was removed by 
detergent treatment and isolated cores were analysed by negative-stain electron microscopy. Electron microscopy pictures 
shown are representative of observations performed on 20 to 60 cores. The scale is indicated (90 nm) and is identical for all 
images shown. (B) Uncoating activity of WT and mutant cores. Results are normalized according to uncoating activity of WT 
cores. The values represent an average of at least two experiments ± the standard deviation.
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sidering the S178A mutant, stability impairment may be
deleterious for steps lying between the final RT and inte-
gration (i.e. formation of LTR ends or viral DNA nuclear
import). It must be considered that a nuclear import
defect may account for the lack of infectivity observed.
Relationships that exist between core organization/stabil-
ity and early replicative steps still remain unclear. How-
ever, it is conceivable that structural properties of the core
may modulate RT and/or subsequent steps. Indeed, mod-
ifications in core morphology are observed during the RT
process [3]. In contrast, the efficiency of RT is enhanced in
reorganizing the core through the use of detergent [2].
Such modifications may however be subtle since the pres-
ence of intact cores has recently been detected in the cyto-
plasm of infected cells [6,43,44]. Altogether, these
observations support that the persistence of the CA shell
in an appropriate state, while part or all of the RT step, is
required for early post-entry steps.
Mutation of the S149 residue also resulted in a profound
defect in virus infection of MAGIC-5B cells. Maturation
and stability of the assembled mutant cores were unaf-
fected in vitro and no defect could be identified using bio-
chemical approaches. Only slight morphological changes
were revealed from electron microscopy imaging of cell
free S149 viruses and isolated cores. The lack of infectivity
observed for this mutant may thus result from subtle
defects in CA assembly. This hypothesis was further con-
firmed using saturation assays of TRIM restriction factors
performed in Cos7 monkey cells, as S149A viruses failed to
release TRIM-mediated restriction observed in these cells.
This phenotype is consistent with the location of S149
within the flexible linker connecting the N- and C-termi-
nal domain of CA which contributes to retroviral core
assembly, probably through the stabilization of dimeric
CA contacts [16]. Analyzing proviral DNA synthesis, S149A
was found altered at the level of first-strand transfer DNA
and subsequent steps that resulted in abolition of 2-LTR
formation. Such defects may result from the inappropriate
assembly of the core but are not related to instability of
the CA shell.
It is evident from our study that replication defects gener-
ated by alanine substitutions of S149 and S178 residues can
be overcome when viral particles are pseudotyped with
VSV-G. Indeed, VSV-G-S149A and VSV-G-S178A efficiently
supported RT and 2-LTR circle formation. Furthermore,
VSV-G pseudotyping was found to enhance efficiency of
late RT in cells infected with the S149A mutant. Interest-
ingly, S149A and S178A mutants were not or poorly rescued
by incorporation of MLV Env that triggers the viral core
into the host cell cytoplasm by fusion at the plasma mem-
brane. Distinct defects in proviral DNA production, asso-
ciated with mutations that modify core assembly or
stability, are thus circumvented by targeting virus entry to
a different compartment of the cell. Pathways that may
route the nucleoprotein viral complexes after fusion and
delivery to the host cell are not clearly defined. An increas-
ing amount of evidence suggests that the cytoskeleton of
the target cell facilitates early steps of HIV-1 infection.
Tracking fluorescent viral complexes in living cells
infected with VSV-G pseudotyped virus demonstrated that
short distance rapid movements of HIV-1 cores are char-
acteristic for an actin-polymerization-dependent trans-
port [6,44]. The same studies reported that the
microtubule network supports long distance movement
of HIV-1 core complexes. In cells infected with non pseu-
dotyped HIV-1, RT is impaired by the use of an actin-
depolymerization agent [12]. However, actin-cable-
dependent trafficking systems recruited by HIV-1 com-
plexes delivered through HIV Env and VSV-G may differ.
Indeed, HIV-1 infection is blocked at the RT level in cells
expressing siRNAs to the Arp2/3 actin nucleator complex,
which inhibits polymerization of actin. This block is no
longer observed using VSV-G pseudotyped HIV-1 [13].
Here, we found that VSV-G incorporation restores infec-
tivity of S149A and S178A mutants. Accordingly, the rela-
tionships between the different phenotypes observed
upon incorporation of HIV-Env and VSV-G and the
recruitment of different trafficking pathways in the host
cell must be considered. In this context, core defects
reported herein for S149A and S178A mutants may affect
the capacity of the viral reverse transcription complex to
relocalize to an appropriate site in the host cell cytoplasm.
The ability of S178A and S149A cores to traffic into the tar-
get cell after viral fusion, and the characterization of
reverse transcription/preintegration complexes formed in
the infected cells, would provide further understanding in
the contribution of the CA shell during HIV-1 post-entry
steps.
In contrast, the restoration of infectious properties was
not observed for S109A virions pseudotyped with VSV-G.
This phenotype correlates with an early and total block in
first-strand transfer DNA synthesis observed in cells
infected with the S109A mutant. Furthermore, S109A substi-
tution was found to dramatically impair Gag precursor
processing and in vivo core assembly. Thus, this study does
not confirm a previous report by Wacharapornin et al.
[28] stating that assembled cores may be purified from
S109A mutated viruses. Impairment of core assembly and
maturation defects observed from this mutant agree with
the position of the S109 residue at a proximity of α-helix 6,
an assembly sensitive surface required for core formation
[23] that undergoes spatial rearrangements during capsid
assembly [45]. Interestingly, a conserved serine residue is
present at the corresponding position in the SIV capsid
protein. Substitution of this amino-acid with alanine
resulted in mild processing defects in cell free virions [46],Retrovirology 2008, 5:57 http://www.retrovirology.com/content/5/1/57
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a phenotype reminiscent of that reported for the HIV-1
S109A mutant in the present study.
A question that remains to be addressed is the potential
contribution of post-translational modifications in regu-
lating CA assembly, maturation and stability. S109, S149
and S178 residues have previously been identified as major
phosphorylation sites in CA [27]. Recent reports showed
that incoming HIV-1 cores, accumulated as stable com-
plexes in the cytoplasm of quiescent T lymphocytes, sup-
port viral gene expression upon serum stimulation of the
host cell [43]. Furthermore, in vitro dissociation of HIV-1
cores is stimulated by addition of cell extract prepared
from activated T lymphocytes [47]. Very recently, muta-
tions in CA were found to inhibit HIV-1 replication in
non-dividing cells in a cell-type dependent fashion, sug-
gesting that CA may be the target of cellular factors regu-
lating the role of incoming viral cores in target cells [48].
According to these data, the regulation of the shape/stabil-
ity of HIV-1 CA by cellular factors may determine the traf-
ficking ability of incoming viral cores. The contribution of
cellular kinases, the presence of which has been detected
in purified HIV-1 particles, [49-52] has to be considered
in this context. Analyzing the dynamics of CA phosphor-
ylation during Gag processing, assembly of mature CA
and early post-fusion steps may provide a crucial insight
into early replicative steps.
Materials and methods
Plasmids
pNL4.3 and pR7-GFP HIV-1 molecular clones [39], pHEF-
VSV-G [53] and SV-A-MLV-env [54] vectors encoding
envelope glycoproteins of VSV and MLV, respectively,
were obtained through the AIDS Research and Reference
Reagent Program, NIAID, NIH. pNL4.3S109A, pNL4.3S149A,
and pNL4.3S178A molecular clones have been described
elsewhere [27].
Viral stock production
Viruses were produced by transfection of 293T cells with
HIV-1 molecular clones using the JetPei transfection rea-
gent (QBiogen). Pseudotyping of HIV-1 viruses was
achieved by co-transfection with the pHEF-VSV-G or the
SV-A-MLV-env plasmid. Two days after transfection, virus-
containing supernatants were collected, filtered onto 0.22
μM membranes, aliquoted and stored at -80°C.
Infectivity assays
MAGIC-5B indicator cells, which stably express the β-
galactosidase reporter gene cloned downstream of the
HIV-1 LTR promoter, were plated at 8 × 104 cells per well,
in 24-well plates and exposed to HIV-1 stock solutions
normalized according to RTase activity determined as pre-
viously reported [55]. Forty-eight hours post-infection,
viral infectivity was monitored by quantification of o-
nitrophenyl β-D-galactopyranoside hydrolysis from cell
lysates as previously described [55]. β-galactosidase activ-
ity was evaluated by measuring absorbance at 405 nm and
was normalized according to total protein content in the
cell lysate.
PCR analysis of viral DNA in infected cells
Total DNA was extracted from MAGIC-5B cells (8 × 104)
infected for 24 h with normalized amounts (4.5 × 104 cpm
RTase activity) of DNAseI-treated virus. The presence of
contaminating pNL4.3 plasmid DNA was checked as pre-
viously described [27]. HIV-1 DNA synthesis was then
monitored by qPCR as follows: 100 ng total DNA sample
were added to the reaction mix containing 0.4 μM of each
primer, and 2 μl SYBR Green master amplification mix
(Fast start DNA Master plus SYBR Green I amplification
kit, Roche). For each amplification, a control reaction was
performed in which DNA sample was replaced by water.
Reactions were subjected to a first cycle of 10 min at 95°C
followed by 40 amplification cycles of 15 s at 95°C; 15 s
at 65°C and 20 s at 72°C on the RotorGene system (Lab-
gene). Fluorescence signal was recorded at the end of each
cycle. A standard curve was generated from 10 to 100,000
copies of pNL4.3 plasmid. The copy numbers of HIV-1
DNA were normalized to that of the GAPDH DNA quan-
tified in parallel as an endogenous control. Primers used
for amplification were: strong-stop DNA: 5'-AAGCAGT-
GGGTTCCCTAGTTAG-3' and 5'-GGTCTCTCTGGTTA-
GACCA-3'; first-strand transfer: 5'-
AGCAGCTGCTTTTTGCCTGTACT-3' and 5'-ACACAACA-
GACGGGCACACAC-3'; full-length minus strand, 5'-
CAAGTAGTGTGTGCCCGTCTGTT-3' and 5'-CCTGCGTC-
GAGAGAGCTCCTCTGG-3' and second-strand transfer 5'-
AGCAGCTGCTTTTTGCCTGTACT-3' and 5'-CCTGCGTC-
GAGAGAGCTCCTCTGG-3'. Amplification of 2-LTR cir-
cles was performed as previously reported [56].
Endogenous reverse transcription assay
Sucrose cushion-purified virus particles (normalized
according to exogenous RTase activity to 4.5 × 104 cpm)
were incubated for 18 h at 37°C in the presence of 0.2
mM Triton X-100, 10 mM Tris, pH 7.4, 10 mM MgCl2, and
200 μM of each dNTP in a final volume of 50 μl. A no-
nucleotide control reaction mixture was always included.
Nucleic acids were then extracted once with phenol:chlo-
roform:isoamyl alcohol (25:24:1) and once with chloro-
form, and precipitated with ethanol. Purified products
were resuspended in 50 μl of water and used (2.5 μl) in
qPCR experiment as described above.
TRIM saturation assay
5 × 104 OMK or Cos7 cells were plated in 24-well plates
the day before infection. The cells were co-infected with
VSV-pseudotyped HIV-1 or CA mutant particles and
superinfected 3 hours later with an appropriate dose (200Retrovirology 2008, 5:57 http://www.retrovirology.com/content/5/1/57
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ng CA) of VSV-pseudotyped HIVR7-GFP reporter virus.
Two days after inoculation, cells were detached using
trypsin and analyzed for GFP expression using an EPICS
PROFILE XL4C cytometer (Beckman Coulter). Values
were reported as the percentage of GFP+ cells in the cul-
ture. VSV-G-pseudotyped HIV-GFP reporter particles were
titrated onto each cell line to determine the appropriate
dose for use in the restriction assay.
Electron Microscopy Analysis
Virus-producing cells were processed for thin-layer elec-
tron microscopy as described elsewhere [55]. For negative
staining, 20 μl sample core suspensions were applied to
Formvar-coated grids (mesh size, 200) and stained with
2% uranyl acetate for 1 min. Preparations were examined
with a Hitachi H.7100 transmission electron microscope.
Immunoblotting analysis
Cell or cell-free virions pelleted by ultracentrifugation
(350,000 g, 5 min at 4°C) were solubilized in SDS-PAGE
sample buffer and separated on a 12.5% SDS-PAGE. Pro-
teins transferred to PVDF membrane (Millipore) were
revealed using a rabbit polyclonal serum directed to RT
(kindly provided by J. L. Darlix, ENS, Lyon, France) or
CypA (Biomol Research Laboratories Inc.), and mAbs
raised against CA (IOT34A clone; Abcam) or actin (C4
clone; MP Biomedicals). Secondary antibodies conjugated
to horseradish peroxidase were revealed by enhanced
chemiluminescent detection (Pierce Biotechnology, Inc.).
Core isolation and in vitro uncoating assay
Viral cores were purified by a spin-through technique.
Briefly, cell free virions were loaded onto the top of a dis-
continuous sucrose density gradient composed of 1 ml
50% sucrose at the bottom covered by 1 ml Triton 0.1%
in 10% sucrose and centrifuged at 100,000 g in a SW50.1
rotor (Beckman) for 2 h at 4°C. Cores were then resus-
pended in PBS and stored at -80°C. In vitro uncoating was
assayed by incubating purified cores diluted in 10 mM
Tris HCl pH 7.4, 100 mM NaCl, 1 mM EDTA for 2 h at
4°C or at 37°C. After ultracentrifugation for 20 min at
13,800 g, 4°C, the extent of core dissociation was calcu-
lated by the ratio of CA detected in the supernatant (oli-
gomeric CA) to that present in pellets (assembled cores)
by anti-CA ELISA assay.
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